Complete Revascularization and Survival in STEMI
References
- Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007; 28(14): 1709–16. DOI: 10.1093/eurheartj/ehm184
- Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): An open-label, randomised controlled trial. Lancet. 2015; 386(9994): 665–71. DOI: 10.1016/S0140-6736(15)60648-1
- Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: The CvLPRIT trial. J Am Coll Cardiol. 2015; 65(10): 963–72. DOI: 10.1016/j.jacc.2014.12.038
- Mehta SR, Wood DA, Storey RF, et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2019; 381(15): 1411–21. DOI: 10.1056/NEJMoa1907775
- Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. N Engl J Med. 2017; 376(13): 1234–44. DOI: 10.1056/NEJMoa1701067
- Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013; 369(12): 1115–23. DOI: 10.1056/NEJMoa1305520
- Hlinomaz O, Groch L, Poloková K, et al. Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: Complete revascularisation versus conservative strategy. Prague-13 trial. Kardiol Rev Int Med. 2015; 17: 214–20.
- Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol. 2009; 104(4): 507–13. DOI: 10.1016/j.amjcard.2009.04.016
- Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010; 3(1): 22–31. DOI: 10.1016/j.jcin.2009.10.017
- Iqbal MB, Ilsley C, Kabir T, et al. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Circ Cardiovasc Qual Outcomes. 2014; 7(6): 936–43. DOI: 10.1161/CIRCOUTCOMES.114.001194
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72(18): 2231–64. DOI: 10.1016/j.jacc.2018.08.1038
- Hicks KA, Mahaffey KW, Mehran R, et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018; 137(9): 961–72. DOI: 10.1161/CIRCULATIONAHA.117.033502
- Iqbal MB, Nadra IJ, Ding L, et al. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease. JACC Cardiovasc Interv. 2017; 10(1): 11–23. DOI: 10.1016/j.jcin.2016.10.024
- Dimitriu-Leen AC, Hermans MP, Veltman CE, et al. Prognosis of complete versus incomplete revascularisation of patients with STEMI with multivessel coronary artery disease: An observational study. Open Heart. 2017; 4(1): e000541. DOI: 10.1136/openhrt-2016-000541
- Galvao Braga C, Cid-Alvarez AB, Redondo Dieguez A, et al. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry. Rev Esp Cardiol (Engl Ed). 2017; 70(6): 425–32. DOI: 10.1016/j.rec.2016.09.027
- Bravo CA, Hirji SA, Bhatt DL, et al. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease. Cochrane Database Syst Rev. 2017; 5: CD011986. DOI: 10.1002/14651858.CD011986.pub2
- Hanratty CG, Koyama Y, Rasmussen HH, Nelson GI, Hansen PS, Ward MR. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: Implications for immediate multivessel revascularization. J Am Coll Cardiol. 2002; 40(5): 911–6. DOI: 10.1016/S0735-1097(02)02049-1
- Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009; 360(3): 213–24. DOI: 10.1056/NEJMoa0807611
- Heusch G, Kleinbongard P, Bose D, et al. Coronary microembolization: From bedside to bench and back to bedside. Circulation. 2009; 120(18): 1822–36. DOI: 10.1161/CIRCULATIONAHA.109.888784
- Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med. 2009; 150(3): 170–7. DOI: 10.7326/0003-4819-150-3-200902030-00006
- Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165. DOI: 10.1093/eurheartj/ehy394
DOI: https://doi.org/10.5334/gh.1040 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 28, 2021
Accepted on: Sep 9, 2021
Published on: Sep 29, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2021 Miha Sustersic, Miha Mrak, Polona Svegl, Anamarija Rebolj Kodre, Igor Kranjec, Zlatko Fras, Matjaz Bunc, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.